Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
33.50
+0.10 (0.30%)
At close: Jul 24, 2025, 4:00 PM
33.65
+0.15 (0.45%)
After-hours: Jul 24, 2025, 7:55 PM EDT

Viking Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Selling, General & Admin
57.5249.2837.0216.1210.710.73
Upgrade
Research & Development
155.32101.6463.8154.2344.9831.93
Upgrade
Operating Expenses
212.84150.92100.8370.3655.6842.66
Upgrade
Operating Income
-212.84-150.92-100.83-70.36-55.68-42.66
Upgrade
Interest Expense
-0.1-0.09-0.09-0.06-0.02-0.11
Upgrade
Interest & Investment Income
41.2740.9415.021.590.73.23
Upgrade
Currency Exchange Gain (Loss)
----0.01-
Upgrade
EBT Excluding Unusual Items
-171.66-110.08-85.9-68.83-54.99-39.54
Upgrade
Gain (Loss) on Sale of Investments
0.110.11--0.04-0.04
Upgrade
Pretax Income
-171.55-109.96-85.9-68.87-54.99-39.5
Upgrade
Net Income
-171.55-109.96-85.9-68.87-54.99-39.5
Upgrade
Net Income to Common
-171.55-109.96-85.9-68.87-54.99-39.5
Upgrade
Shares Outstanding (Basic)
11210994777773
Upgrade
Shares Outstanding (Diluted)
11210994777773
Upgrade
Shares Change (YoY)
7.91%15.57%22.79%-0.47%6.34%0.89%
Upgrade
EPS (Basic)
-1.54-1.01-0.91-0.90-0.71-0.54
Upgrade
EPS (Diluted)
-1.54-1.01-0.91-0.90-0.71-0.54
Upgrade
EBIT
-212.84-150.92-100.83-70.36-55.68-42.66
Upgrade
Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q